Chad J Achenbach Selected Research

C-Reactive Protein

11/2023

A Multicenter Retrospective Cohort Study to Characterize Patients Hospitalized With Multisystem Inflammatory Syndrome in Adults and Coronavirus Disease 2019 in the United States, 2020-2021.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chad J Achenbach Research Topics

Disease

17	COVID-19 04/2024 - 12/2020
14	Neoplasms (Cancer) 11/2023 - 03/2011
13	Infections 04/2024 - 02/2011
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 03/2011
4	Tuberculosis (Tuberculoses) 01/2020 - 06/2013
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 06/2014
4	Lymphoma (Lymphomas) 01/2017 - 08/2013
3	HIV Infections (HIV Infection) 01/2020 - 02/2011
3	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2017 - 10/2015
3	Viremia 01/2016 - 01/2014
2	Breakthrough Infections 07/2022 - 09/2021
2	Anus Neoplasms (Anal Cancer) 01/2022 - 01/2020
2	Coinfection 01/2022 - 01/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 01/2016
2	Immune Reconstitution Inflammatory Syndrome 07/2014 - 02/2012
1	COVID-19 related adult multisystem inflammatory disease 11/2023
1	Pneumonia (Pneumonitis) 03/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2022
1	Human Influenza (Influenza) 03/2022
1	Alcoholism (Alcohol Abuse) 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Hepatitis 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2018
1	Pathologic Constriction (Stenosis) 06/2018
1	Carcinogenesis 01/2018
1	Heart Failure 11/2017
1	Myocardial Infarction 01/2017
1	Lung Neoplasms (Lung Cancer) 10/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2015
1	Pulmonary Tuberculosis 05/2015
1	Obstructive Lung Diseases (Obstructive Lung Disease) 05/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2015
1	Hepatitis B 07/2014
1	Persistent Infection 01/2014
1	Opportunistic Infections (Opportunistic Infection) 02/2012
1	Hyperlipidemias (Hyperlipidemia) 02/2011
1	Insulin Resistance 02/2011

Drug/Important Bio-Agent (IBA)

14	RNA (Ribonucleic Acid)IBA 09/2023 - 03/2011
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2018
5	Explosive Agents (Explosives)IBA 01/2021 - 12/2020
4	COVID-19 VaccinesIBA 04/2024 - 09/2021
4	AntigensIBA 01/2023 - 01/2022
3	Viral RNAIBA 09/2023 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2023 - 06/2015
2	AntibodiesIBA 01/2023 - 01/2014
2	Coffee FDA Link 03/2022 - 06/2021
2	Antiviral Agents (Antivirals)IBA 01/2022 - 06/2015
2	VaccinesIBA 01/2021 - 01/2021
1	C-Reactive ProteinIBA 11/2023
1	fibrin fragment D (D-dimer)IBA 11/2023
1	ProcalcitoninIBA 11/2023
1	Ferritins (Ferritin)IBA 11/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Nucleocapsid ProteinsIBA 01/2023
1	EpitopesIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	TeaIBA 03/2022
1	Caffeine (No Doz)FDA LinkGeneric 03/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Complement System Proteins (Complement)IBA 08/2021
1	Hepatitis B e AntigensIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 11/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 12/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2018
1	SmokeIBA 05/2015
1	GoldIBA 05/2015
1	Bronchodilator Agents (Bronchodilators)IBA 05/2015
1	N-acetoacetyl-N-deacetylcolchicineIBA 04/2014
1	Broadly Neutralizing AntibodiesIBA 01/2014
1	BilirubinIBA 02/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2011
1	Atazanavir Sulfate (Reyataz)FDA Link 02/2011
1	Ritonavir (Norvir)FDA Link 02/2011

Therapy/Procedure

17	Therapeutics 01/2022 - 03/2011
11	Art Therapy 01/2022 - 02/2012
6	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 02/2011
1	Percutaneous Coronary Intervention 06/2018
1	Aftercare (After-Treatment) 01/2018
1	Drug Therapy (Chemotherapy) 01/2017
1	Hysterectomy 01/2016